Healthtech Investors & VC Firms in China
267 firms in this list, with a median first check of $1M. 44 of them lead rounds. Generated from verified public data and updated continuously.
Tiantu Capital
ShenzhenSeed–Late Stage
4 people
Huangpu River Capital
ShanghaiGrowth–Late Stage
Long Hill Capital
Grand CaymanSeries A–Growth
3 people
Trustbridge Partners
ShanghaiSeries B–Late Stage
5 people
Gaorong Capital
BeijingSeed–Series B
5 people
Danen Capital
ShenzhenSeed–Growth
2 people
TriWise Capital
ShenzhenSeed–Series C
2 people
Legend Star
BeijingPre-Seed–Series A
5 people
Haibang Capital
HangzhouPre-Seed–Series A
1 person
TTM
Seed
China Renaissance – Huaxing New Economy Funds
BeijingSeed–Growth
SenseTime
Shanghai
Shanda Capital
ShanghaiGrowth
Shiyu Capital
HainanSeed–Late Stage
CDF-Capital
ShenzhenSeed–Late Stage
Haier Capital
ShanghaiSeed–Growth
Holley Group
JD Capital
NanchangSeed–Late Stage
New Access Capital
ShanghaiGrowth
NextView Capital
QF Capital
ShenzhenPre-Seed–Series A
Zhejiang Paradise
HangzhouSeries A–Growth
Redpoint Ace Ventures
ShanghaiSeed–Late Stage
5 people
Jeneration Capital
Grand Cayman, KySeries B–Growth
4 people
Related lists
Investors & VC Firms in North America (13118)Investors & VC Firms in United States (12145)Investors & VC Firms in Europe (5954)AI & Machine Learning Investors & VC Firms (5127)Investors & VC Firms in Global (5099)Fintech Investors & VC Firms (4949)Healthtech Investors & VC Firms (4486)SaaS Investors & VC Firms (4408)Enterprise Software Investors & VC Firms (4306)Crypto & Web3 Investors & VC Firms (4087)
Data sourced from public filings and firms' own websites — see our methodology.










